SHSE:688566 (China)
Â
Class A
Â¥
26.05
(-1.33%)
Apr 26
Business Description
Jiangsu Jibeier Pharmaceutical Co Ltd
ISIN : CNE100004041
Share Class Description:
SHSE:688566: Class ACompare
Compare
Traded in other countries / regions
688566.China IPO Date
2020-05-18Description
Jiangsu Jibeier Pharmaceutical Co Ltd specializes in the research, development, production and sales of chemical preparations, proprietary Chinese medicine preparations, and bulk medicines. The company's products include tablets, hard capsules, eye drops, and gels, agents, creams and other dosage. Its products are used in various application fields such as Cardiovascular drugs, Blood system drugs, Immune system drugs, Ophthalmic drugs, Antipyretic and analgesic drugs, Respiratory medicine, and other.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2544.86 | |||||
| Equity-to-Asset | 0.87 | |||||
| Interest Coverage | 946.38 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 10.77 | |||||
| Beneish M-Score | -1.19 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -3.3 | |||||
| 3-Year EBITDA Growth Rate | -0.7 | |||||
| 3-Year EPS without NRI Growth Rate | -2.9 | |||||
| 3-Year Book Growth Rate | 39.8 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 71.63 | |||||
| 9-Day RSI | 63.56 | |||||
| 14-Day RSI | 58.42 | |||||
| 6-1 Month Momentum % | -0.24 | |||||
| 12-1 Month Momentum % | -15.29 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.99 | |||||
| Quick Ratio | 5.8 | |||||
| Cash Ratio | 4.04 | |||||
| Days Inventory | 135.96 | |||||
| Days Sales Outstanding | 67.08 | |||||
| Days Payable | 340.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.92 | |||||
| Dividend Payout Ratio | 0.38 | |||||
| Forward Dividend Yield % | 1.84 | |||||
| 5-Year Yield-on-Cost % | 0.91 | |||||
| 3-Year Average Share Buyback Ratio | -10.1 | |||||
| Shareholder Yield % | 1.08 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 88.93 | |||||
| Operating Margin % | 30.12 | |||||
| Net Margin % | 27.27 | |||||
| FCF Margin % | -24.92 | |||||
| ROE % | 13.37 | |||||
| ROA % | 11.55 | |||||
| ROIC % | 24.49 | |||||
| ROC (Joel Greenblatt) % | 40.85 | |||||
| ROCE % | 14.5 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 21.01 | |||||
| PE Ratio without NRI | 20.63 | |||||
| Price-to-Owner-Earnings | 38.14 | |||||
| PEG Ratio | 17.19 | |||||
| PS Ratio | 5.73 | |||||
| PB Ratio | 2.68 | |||||
| Price-to-Tangible-Book | 2.77 | |||||
| Price-to-Operating-Cash-Flow | 34.1 | |||||
| EV-to-EBIT | 15.95 | |||||
| EV-to-EBITDA | 15.95 | |||||
| EV-to-Revenue | 4.97 | |||||
| EV-to-FCF | -16.29 | |||||
| Price-to-Graham-Number | 1.59 | |||||
| Price-to-Net-Current-Asset-Value | 5.89 | |||||
| Price-to-Net-Cash | 10.42 | |||||
| Earnings Yield (Greenblatt) % | 6.27 | |||||
| FCF Yield % | -4.28 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Jiangsu Jibeier Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 845.136 | ||
| EPS (TTM) (Â¥) | 1.24 | ||
| Beta | 1.5 | ||
| Volatility % | 51.35 | ||
| 14-Day RSI | 58.42 | ||
| 14-Day ATR (Â¥) | 1.19683 | ||
| 20-Day SMA (Â¥) | 24.114 | ||
| 12-1 Month Momentum % | -15.29 | ||
| 52-Week Range (Â¥) | 17.49 - 41.96 | ||
| Shares Outstanding (Mil) | 189.08 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Jiangsu Jibeier Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Jiangsu Jibeier Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Jiangsu Jibeier Pharmaceutical Co Ltd Frequently Asked Questions
What is Jiangsu Jibeier Pharmaceutical Co Ltd(SHSE:688566)'s stock price today?
The current price of SHSE:688566 is ¥26.05. The 52 week high of SHSE:688566 is ¥41.96 and 52 week low is ¥17.49.
When is next earnings date of Jiangsu Jibeier Pharmaceutical Co Ltd(SHSE:688566)?
The next earnings date of Jiangsu Jibeier Pharmaceutical Co Ltd(SHSE:688566) is .
Does Jiangsu Jibeier Pharmaceutical Co Ltd(SHSE:688566) pay dividends? If so, how much?
The Dividend Yield %  of Jiangsu Jibeier Pharmaceutical Co Ltd(SHSE:688566) is 0.92% (As of Today), Highest Dividend Payout Ratio of Jiangsu Jibeier Pharmaceutical Co Ltd(SHSE:688566) was 0.96. The lowest was 0.35. And the median was 0.64. The  Forward Dividend Yield % of Jiangsu Jibeier Pharmaceutical Co Ltd(SHSE:688566) is 1.84%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers